The global human growth hormone market size was valued at USD 6.81 billion in 2024 and is projected to reach from USD 7.63 billion in 2025 to USD 18.75 billion by 2033, growing at a CAGR of 11.90% ...

Novo Nordisk has agreed to cap insulin prices at $35, settling a lawsuit from Minnesota's Attorney General over allegations ...

Eli Lilly and Company (LLY ... indicating a potential upside of 25.7% from the current levels. With headquarters in the heart of Chicago's financial district, Barchart has been an industry ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Homegrown injection-molding company Core Technology Molding Corp. has closed on the property for its own production and headquarters ... Merck, and Eli Lilly. The target for moving is November ...

That's among 35 predictions I'm offering for the new year, ranging from politics to business to sports. I've never published this many predictions before. I wanted to try it this year in order to test ...

Republican Indiana Attorney General Todd Rokita is suing St. Joseph County alleging its jail is breaking a new state law by not cooperating with federal immigration officials.

Indiana University announced Friday that it’s raising pay for graduate students with part-time research or teaching duties, but the union representing the workers isn’t satisfied.

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.